
The study explored the association between thyroid peroxidase antibody (TPOAb) positivity in the first trimester and maternal metabolic syndrome during pregnancy in a retrospective review of 787 singleton pregnancies. Women positive for TPOAb exhibited significantly lower baseline HDL-C (1.51 vs. 1.62 mmol/L, p = 0.028) and higher rates of hypertensive disorders complicating pregnancy (15.8% vs. 6%, p < 0.0001), maternal metabolic syndrome (18.8% vs. 6.4%, p < 0.0001), and preeclampsia (7% vs. 2.5%, p = 0.024). Nonlinear associations between TPOAb levels and HDCP or metabolic syndrome were observed (both p < 0.001). Adjusted analyses revealed significantly elevated risks of HDCP (OR 3.029), metabolic syndrome (OR 2.841), and preeclampsia (OR 3.315).
Like
Save
Share